Video & Transcript Research : 'pharmaceutical'

Page 9 of 56
MO

Missouri 2026 Regular Session

2026 Legislative Session - Day Seventy One - Friday, May 15 - Afternoon Session

Missouri House Floor Meeting

Transcript Highlights:
  • projects, and Missouri is home to some of the most important assets needed by the defense and pharmaceutical
  • projects, and Missouri is home to some of the most important assets needed by the defense and pharmaceutical
  • I mean, during COVID, India cut off our supply to critical brain cancer treatments for pharmaceuticals
  • by the United States Department of Interior on the critical material side and on the critical pharmaceutical
  • Yeah, it's adding critical materials and pharmaceuticals. I guess that's what you mean.
Keywords: 959, house, all
MO

Missouri 2026 Regular Session

2026 Legislative Session - Day Seventy One - Friday, May 15 - Afternoon Session

Missouri House Floor Meeting

Transcript Highlights:
  • projects, and Missouri is home to some of the most important assets needed by the defense and pharmaceutical
  • I mean, during COVID, India cut off our supply to critical brain cancer treatments for pharmaceuticals
  • On the pharmaceutical side, they're going to be identified and published in the list provided by the
  • Yeah, it's adding critical materials and pharmaceuticals. I guess that's what you're...
  • Yeah, it's adding critical materials and pharmaceuticals. I guess that's what you mean.
Summary: The House took up a series of conference committee reports and third-read Senate bills near the end of session, with several members also recognizing House drafters and research staff. The chamber first adopted and finally passed Senate Joint Resolution 87, which drew debate over whether the measure would remove the City of St. Louis sheriff as an elected office; supporters said the change also applied to other charter governments, while opponents argued it reduced local autonomy. The report and final passage both succeeded on 95-46 votes. Members then adopted and finally passed Senate Bill 973, a package combining a wholesaler/real estate transparency measure with a land bank provision. Senate Bill 1421, a broad public safety bill, was also advanced after a motion to exceed the conference differences; supporters highlighted provisions on clean slate, masked intimidation, prosecuting attorney salaries, fentanyl, gift card fraud, unmanned aircraft, and other public safety items. The conference report passed 116-18, the bill finally passed 110-25, and the emergency clause for the drone-related portion passed 136-5. The House also adopted and finally passed Senate Bills 835 and 1111, a combined conference report that included insurance consumer protections, court administration updates, treatment court and judgeship provisions, a St. Louis civil case surcharge, and the Uniform Public Expression Protection Act. Senate Bill 1408 was stripped back to a single issue authorizing MoDOT to consider raising rural interstate speed limits from 70 to 75 mph, and it passed 93-46. Senate Bill 913, extending several agriculture tax credits and adding a short line railroad credit, prompted extended debate over tax credits, budget pressures, and whether such incentives should be extended now or later; a proposed child tax credit amendment was withdrawn, and the bill ultimately passed 107-30. The House then began debate on Senate Bill 1553, a critical minerals and pharmaceutical manufacturing incentive bill, with supporters framing it as a jobs and supply-chain security measure and opponents raising questions about tax incentives and local impacts.
US
Transcript Highlights:
  • During COVID, we were unable to procure semiconductors to build our cars or materials for pharmaceuticals
  • question I have for you, there's no doubt that we have offshored some very crucial products, pharmaceuticals
  • This includes semiconductors, it includes pharmaceuticals. like you're talking about, certain metals
  • So we are doing investigations right now, and we're considering, with respect to pharmaceuticals and
  • For now, we've excluded pharmaceuticals and semiconductors to take a different kind of Let's get to another
Summary: The meeting focused on various significant topics concerning the recent tariff policies and their wide-ranging implications on the American economy. Members expressed their concerns regarding the negative impact of increased tariffs as proposed by the Trump administration, with specific emphasis on how families might suffer from higher costs and market access issues. The discussion was lively, with members questioning the clarity of the tariff plan and raising concerns about its potential effects on small businesses and American exports.
US
Transcript Highlights:
  • Pharmaceuticals, and we want to do it in a way that's affordable.
  • These key components, whether it's specialty metals, minerals, or active pharmaceutical ingredients,
  • was surprised to find out is That we really don't produce the precursor chemicals or the active pharmaceutical
  • Pharmaceuticals, for sure, is one that I think we need to look at.
  • Manufacturing lots and lots of products, including glass, detergent, pharmaceuticals, whether it's oil
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Emergency Preparedness and Management Jun 21st, 2026 at 01:00 pm

Joint Committee on Emergency Preparedness and Management

Transcript Highlights:
  • The push to vaccinate ignores that pharmaceuticals historically only care about profits and cover up
  • We do not want to have a mandate when pharmaceuticals can decide.
  • I have a doctorate in polymer chemistry, and for part of my career, I worked in the pharmaceutical industry
  • that the people in Massachusetts are never again required to take an experimental liability-free pharmaceutical
  • ..the people in Massachusetts are never again required to take an experimental liability-free pharmaceutical
Keywords: 995, all
Summary: The Joint Committee on Emergency Preparedness and Management held a hearing on several emergency management bills, with most of the testimony focused on Senate Bill 539, which would prohibit COVID-19 mRNA vaccination or gene-altering procedures as a condition of entry, employment, school attendance, or access to public venues. Senator Durant and many public witnesses supported the bill, arguing that COVID-era mandates were coercive, ineffective, and harmful, and that the state should not require proof of vaccination in future emergencies. One witness, Joanne Tuller, testified in opposition, saying the government should retain authority to impose public health measures in emergencies and warning against permanently limiting that power based on the COVID experience. The committee also heard testimony on Senate Bill 540, concerning the prevention of radioactive material discharge, with a Sierra Club representative and local residents opposing Holtec’s disposal of wastewater from the Pilgrim Nuclear Power Plant and citing health, environmental, and economic concerns in Plymouth and nearby communities. Senator Driscoll testified in support of Senate Bills 537 and 538, describing them as measures to strengthen the Commonwealth’s strategic preparedness stockpile and to create a framework for emergency response during surges in hospitalizations, including temporary waivers of prior authorization when hospitals are over capacity. In addition, Dr. Jennifer Carlson testified in support of H.885, a resolve creating a special commission on the field of emergency management, arguing that the profession should be more fully professionalized and staffed by dedicated experts rather than part-time “second hat” officials. Several other bills on the docket, including H.883 and H.84, had no sign-ups. The chair closed each bill’s testimony section as the list was exhausted, and the hearing was adjourned without any votes taken during the session.
FL

Florida 2025 Regular Session

Health Policy Feb 18th, 2025

Transcript Highlights:
  • I'M HERE REPRESENTING TODAY ALSO PHARMACEUTICALS ONE OF OUR CLIENTS GOOD AFTERNOON, YOU ARE RECOGNIZED
  • I'M HERE REPRESENTING TODAY ALSO PHARMACEUTICALS ONE OF OUR CLIENTS WHO HAS WORKED WITH CHAIR HARRELL
  • PHARMACEUTICALS HAS SUPPORTED AN INITIATIVE SIMILAR TO SENATE BILL 264.
Keywords: 999, senate, all
TX

Texas 89th Regular

State Affairs Apr 7th, 2025

State Affairs

Transcript Highlights:
  • Without the need for pharmaceuticals.
  • He is 100% pharmaceutical-free.
  • And somehow, I take zero pharmaceuticals. I want to make that very clear.
  • I don't take any kind of pharmaceuticals; every bit of my health...
  • Like most veterans, I was prescribed pharmaceutical drugs from the VA.
Bills: HB28, SB3, SB 3
CA

California 2025-2026 Regular Session

Assembly Health Committee Jun 30th, 2026

Transcript Highlights:
  • Chair and members, Alison Ramey, on behalf of the Pharmaceutical Care Management Association, in support
  • Currently, pharmaceutical companies often offer coupons to privately insured patients to provide discounts
  • Since pharmaceutical companies can change the coupon programs and patient eligibility rules for those
  • Alison Ramey, on behalf of the Pharmaceutical Care Management Association, we are also opposed unless
  • Alison Ramey, on behalf of the Pharmaceutical Care Management Association, we also had an opposed and
Summary: The Assembly Health Committee heard several measures, beginning with SB 331 by Sen. Menjivar, which would require large-group health plans to cover hearing aids for children. The author and supporters described the bill as a long-running effort to address a developmental emergency and reduce out-of-pocket costs for families, while opponents were absent. Testimony from parents, advocates, medical experts, and organizations emphasized the importance of early access to hearing aids; committee members voiced strong support, and the bill was moved on a do-pass basis to Appropriations, with several members requesting to be added as coauthors. The committee then heard SB 608, also by Sen. Menjivar, to expand access to condoms in school-based health centers and related settings and to prevent barriers such as ID checks. Supporters, including students and school health advocates, argued the bill would improve sexual health and reduce stigma, while opponents from family and faith groups argued it would undermine parental authority and normalize early sexual activity. The bill was supported by committee members and moved forward on a do-pass basis to Appropriations. Next, SB 971 by Sen. Choi proposed community-based healthy aging partnerships for older adults, with testimony from the California Senior Legislature and supporters from aging and dementia organizations. The measure was described as voluntary and focused on connection, independence, and local collaboration; there was no opposition, and the committee moved it on a do-pass basis to Appropriations. The committee also heard SB 869 by Sen. Weber Pierson, which would require warning icons and statements on chain restaurant menus for beverages with very high added sugar content. Supporters framed it as a transparency and public health measure, while restaurant and beverage industry representatives opposed it unless amended, citing cost and menu-space concerns; the bill was nevertheless moved on a do-pass basis to Appropriations after a roll call vote, with some members voting no and the measure placed on call. The committee also considered SB 950 by Sen. Weber Pierson, aimed at ensuring timely coverage of FDA-approved, medically necessary treatments for early-onset Alzheimer’s disease on commercial plans. Supporters, including the Alzheimer’s Association and a patient advocate, said the bill would reduce delays and barriers to care, while health plan representatives opposed it over step therapy and utilization-management concerns. Members discussed the limited treatment window and the need for early access, and the bill was moved on a do-pass basis to Appropriations. In addition, SB 490 by Sen. Umberg would set timelines for DHCS investigations of unlicensed sober living homes and allow counties to assist if the department cannot act in time; supporters from Anaheim and a patient-brokering survivor described serious abuse and oversight gaps, while county behavioral health representatives opposed the county role as an unfunded and potentially liability-creating burden. After discussion, the bill was also moved on a do-pass basis to Appropriations. Finally, the committee began hearing SB 1037 by Sen. Weber Pierson on health insurance affordability and rate review, with supporters arguing it would tie premium increases more closely to affordability targets and public reporting; the transcript cuts off before the committee completed action on that measure.
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Consumer Protection and Professional Licensure Jun 21st, 2026 at 01:00 pm

Joint Committee on Consumer Protection and Professional Licensure

Transcript Highlights:
  • I don't know if it's a pharmaceutical front.
  • I don't know if it's a pharmaceutical front that's paying Senator Montigny.
  • I did not go into medicine to serve pharmaceutical profits. I became a doctor to help people heal.
  • The only thing I was offered was a lifetime of pharmaceutical treatment.
  • This bill is about funneling those millions of people back into pharmaceutical-profit medicine.
Keywords: 995, all
Summary: The committee opened a hearing of the Joint Committee on Consumer Protection and Professional Licensure and reviewed a broad agenda including credit card fees, event ticketing, music therapy licensure, senior psychologist licensure, CPA pathways, school mental health licensure, and a bill regulating alternative healing therapies. The chairs explained hearing logistics, including three-minute testimony limits and submission of written testimony, and noted that more than 70 people had signed up to testify. Legislators and advocates were heard out of order throughout the day. A major portion of the hearing focused on credit card surcharge and interchange legislation. Restaurant owners, the Massachusetts Restaurant Association, NFIB, and other small-business witnesses supported bills allowing merchants to add convenience fees and, in one proposal, preventing card companies from charging fees on tax and tip portions of transactions. They argued that swipe fees are a major and growing cost, especially for restaurants, and that Massachusetts is one of only two states that bars surcharges. Opponents from the Cooperative Credit Union Association, the Electronic Payment Coalition, and the Electronic Transactions Association warned that the proposals would create compliance burdens, fragment the payment system, raise legal preemption issues, and disrupt a system they described as efficient and secure. The committee also heard competing testimony on ticket transferability and ticket resale. Supporters, including the National Consumers League and Sports Fans Coalition, said bills on ticket transferability would protect consumers who cannot attend events and would increase competition and savings in the secondary market. Opponents, including United Musicians and Allied Workers and theater owners, argued that mandatory transferability would weaken artists’ and venues’ ability to prevent scalping and predatory resale, and that some ticket sellers should be exempt from the broader ticketing regulations. Separate testimony supported music therapy licensure, senior psychologist licensure, and new CPA education pathways, with witnesses saying these measures would expand access to care and strengthen the workforce while maintaining professional standards. The hearing also drew extensive opposition to S.261 on alternative healing therapies, with practitioners and clients arguing it would overregulate spiritual and holistic practices and was not an effective response to human trafficking concerns.
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Public Health Jun 21st, 2026 at 10:00 am

Joint Committee on Public Health

Transcript Highlights:
  • I now work for B-Bron Medical, a leading medical device and generic pharmaceutical company.
  • should be eliminated except for currently unavoidable and strictly defined medical devices and pharmaceutical
  • I was not able or willing to rely on pharmaceuticals, and kratom gave me a safe and effective way to
  • It is because of kratom's ability to take the place of high-profit pharmaceuticals and be used as an
  • It's so beneficial that it cuts into the profits of the pharmaceutical companies who heavily lobby and
Keywords: 995, all
Summary: The Joint Committee on Public Health held a lengthy hearing to take testimony on a wide range of bills related to environmental health, PFAS, medical device chemicals, food access, lead poisoning, air quality, oral health, and school food additives. Chair Driscoll and Chair Decker emphasized that the hearing was for testimony only, no decisions would be made that day, and that written testimony could still be submitted. They also noted the high volume of speakers and asked witnesses to keep remarks brief. A major portion of the hearing focused on PFAS-related legislation, including bills to restrict PFAS in products and food packaging and to create a PFAS remediation trust fund. Municipal officials and advocates described the high costs of PFAS cleanup, especially for drinking water systems, citing Easton’s multimillion-dollar treatment investments and rate increases. Testimony from legislators and advocates argued that Massachusetts should act despite federal uncertainty, and that the state should stop PFAS at the source rather than leaving municipalities and residents to pay for remediation. The committee also heard strong support for a bill banning DEHP in medical devices, with physicians, nurses, and a bill sponsor saying the chemical can leach from IV bags and tubing and that safer alternatives already exist. The committee also heard testimony on bills to establish statewide food truck permitting, with food truck owners and a senator describing the current system as costly, duplicative, and inconsistent across municipalities. Another set of witnesses supported the “Bean New Deal,” which would expand plant-based food options in public institutions, senior nutrition programs, and WIC, citing health, equity, and cost savings. On lead poisoning, housing advocates and a representative backed bills to expand lead-safe housing requirements to all rental units, arguing the current law contributes to discrimination against families with children and leaves too much pre-1978 housing uncertified. The committee also heard support for an outdoor air pollution bill that would create an advisory committee, identify pollution hotspots, expand monitoring, and set reduction targets, with testimony from environmental justice groups, pediatricians, and legislators describing disproportionate asthma and other health harms in overburdened communities. Later testimony addressed oral health bills to create dental therapists and allow dental hygienists to administer nitrous oxide, with supporters saying the measures would expand access, reduce costs, and help underserved patients. The committee also heard testimony on a bill to prohibit harmful food dyes in competitive school foods, with parents describing behavioral and health concerns tied to synthetic dyes. No votes or formal actions were taken during the hearing.
MS

Mississippi 2026 Regular Session

Public Health and Welfare - Room 216, 3 February, 2026; 3:00 PM

Public Health and Welfare

Transcript Highlights:
  • /c> So with that being the case, obviously the title in section one is the Mississippi Active Pharmaceutical
  • accepted bulk drug substances or APIs, active pharmaceutical ingredients, that meet U.S.
  • grade and quality and pharmaceutical grade and quality and accompanied<01:05:49.680> by<01:05
  • <01:06:05.599> ingredients<01:06:06.079> were active pharmaceutical ingredients were
  • active pharmaceutical ingredients were manufactured<01:06:07.119> in<01:06:07.359> FDA
Summary: The committee met with a quorum and first took up several bills described as vehicles to keep options open for pending rural health issues, especially the rural health transformation fund and the Greenwood Hospital situation. The chair explained that Greenwood Hospital is struggling financially and operationally, including a Medicaid overpayment dispute in which Medicaid planned to recoup $2 million from a December payment, threatening payroll and continued operation. The committee discussed a proposed committee substitute that would delay recoupment until May 1 and preserve legislative flexibility to help Greenwood if a workable plan emerges. The committee adopted motions for title sufficiency and due pass on the block of bills, including the committee substitute and reverse repealer provisions. The committee then turned to two certificate-of-need bills. One bill, 2474, was presented as a rural hospitals measure that would let certain rural hospitals obtain certificates of need for services such as outpatient dialysis units, ambulatory surgical facilities, and geriatric psychiatric units, with definitions aimed largely at Delta and other rural counties. The chair also included a provision making the state health officer’s licensing decision final and not subject to judicial review, with only a short reconsideration process available. Senator Hill objected, arguing the bill concentrated too much power in the health department, eliminated meaningful court review, and unfairly picked winners and losers instead of letting the market work. The chair responded that the goal was to reduce costly, repetitive litigation and preserve access to care in areas where hospitals struggle financially. The committee then considered Senator Blackwell’s broader CO bill, which would address appeals and litigation more generally by shifting costs to the losing party in CO disputes. A reverse repealer was adopted first, and the chair explained that the bill was intended to reduce endless and expensive appeals while still allowing a limited opportunity for reconsideration. Senators Hill and others raised concerns about limiting judicial review and expanding health department power, while the chair said many states have no judicial review in this area and that the committee was exploring the issue further. The chair said he had asked several members to study the matter and contact the National Council of State Legislatures. The committee ultimately adopted the motions on the bills and amendments by voice vote, with the ayes prevailing each time.
CA

California 2025-2026 Regular Session

Assembly Labor and Employment Committee Jun 10th, 2026

Labor and Employment

Transcript Highlights:
  • happy to be here to present SB 1185, which applies skilled and trained workforce standards to pharmaceutical
  • Pharmaceutical facilities are among the most technically complex construction environments in the modern
  • failures, workforce deficiencies, catastrophic incidents, or public safety concerns associated with pharmaceutical
  • all future construction, alteration, repair, installation, demolition, and maintenance work at pharmaceutical
Keywords: 988, house, all
Summary: The Assembly Labor and Employment Committee heard several bills focused on worker protections, enforcement, and technology in the workplace. SB 909 would strengthen enforcement of public works prevailing wage laws by raising contractor registration fees and penalties and directing part of penalty revenue back to enforcement; labor groups supported it as a way to deter wage theft, while contractor groups opposed the fee and penalty increases as burdensome and potentially costly for public projects. The committee members generally expressed support for stronger enforcement but also concern about the state’s backlog and capacity to enforce the law. SB 909 passed on a due pass vote and was re-referred to Appropriations. The committee also considered multiple bills addressing AI and workplace rights. SB 951 would require 60-day notice when technology displaces 25 or more workers and would require reporting on AI-related job impacts; labor and education groups supported it, while business, public sector, and industry groups argued it was premature and overbroad. SB 947 would require human review of automated discipline, termination, or deactivation decisions and prohibit predictive behavior analysis; supporters said it would prevent algorithmic abuse, while opponents raised concerns about independent contractors, private rights of action, and forum shopping. Both bills advanced on party-line style votes to the Committee on Privacy and Consumer Protection. The committee also approved SB 1149, which would expand bereavement leave to cover a “designated person” equivalent to family, with emotional testimony from a witness describing the loss of a long-term partner. Supporters said the bill reflects modern family structures, especially for LGBTQ and older Californians; there was no opposition. SB 1185, applying skilled-and-trained workforce standards to pharmaceutical facility construction, also passed despite opposition from contractors and business groups who said there was no demonstrated safety problem and warned of higher costs and fewer bidders. In addition, the committee approved consent-calendar bills SB 1316, SB 1046, and SB 1059, and left rolls open for absent members before adjourning.
CA
Transcript Highlights:
  • happy to be here to present SB 1185, which applies skilled and trained workforce standards to pharmaceutical
  • Pharmaceutical facilities are among the most technically complex construction environments in the modern
  • failures, workforce deficiencies, catastrophic incidents, or public safety concerns associated with pharmaceutical
  • all future construction, alteration, repair, installation, demolition, and maintenance work at pharmaceutical
Summary: The Assembly Labor and Employment Committee heard several bills focused on worker protections, AI in the workplace, bereavement leave, and construction labor standards. SB 909 by Senator Smallwood-Cuevas would increase public works contractor registration fees, raise prevailing wage and related penalties, and direct half of collected penalties back into the Public Works Enforcement Fund. Supporters said the bill would help combat wage theft and misclassification and strengthen enforcement; opponents argued the higher fees and penalties would burden contractors without fixing enforcement backlogs. The committee voted the bill out on a due pass motion to Appropriations. The committee also approved SB 951 by Senator Reyes, which would require 60-day notice when 25 or more workers are displaced by technology and require reporting on AI-related job impacts. Supporters framed it as a response to rapid AI-driven layoffs and a way to gather real-time data; opponents raised concerns about small employers, proprietary information, and litigation. SB 947 by Senator McNerney, the “No Robo Bosses Act,” would require human review of automated discipline, termination, or deactivation decisions and restrict predictive behavior analysis. Supporters said it would prevent biased or mistaken automated decisions; opponents objected to the inclusion of independent contractors, private rights of action, and other provisions. Both bills were advanced to the Committee on Privacy and Consumer Protection. The committee also passed SB 1149 by Senator Durazo, which would expand bereavement leave to cover a “designated person,” including chosen family relationships. Supporters, including AARP and a witness who described losing a long-term partner, said the bill reflects modern family structures; there was no opposition. In addition, SB 1185 by Senator Cortese, applying skilled and trained workforce standards to pharmaceutical facility construction, was approved despite opposition from business and construction groups who said there was no demonstrated safety problem and that the mandate could raise costs and reduce competition. Several other bills on the consent calendar were also approved, and all measures were reported out of committee.
TX
Transcript Highlights:
  • captured; 19 of the 20 leaders on the nutrition guidelines committee are paid for by the food... pharmaceutical
  • Because the medical... guidelines are created by the American Medical Association, which is a pharmaceutical
  • because of both government incentives and lack of transparency and accountability, the food and pharmaceutical
  • Pharmaceutical interventions have to become central to Texas health policy.
Bills: SB 25, SB25, SB314
FL

Florida 2026 5th Special Session

Health Policy Feb 11th, 2026

Transcript Highlights:
  • In the pharmaceutical world, the PBM negotiates rebates and pricing concessions from drug manufacturers
  • In the pharmaceutical world, the PBM negotiates rebates and pricing concessions from drug manufacturers
  • Michael Cantenz, representing the Pharmaceutical Care Management Association.
  • Michael canton's representing pharmaceutical care management association Thank you, Chair.
  • Michael Cantenz, representing Pharmaceutical Care Management Association.
Summary: The committee first heard Senate Bill 1414 by Sen. Polsky on congenital cytomegalovirus (CMV) education. The bill would require the Department of Health, working with medical experts, to create and distribute CMV educational materials to expectant and new parents or caregivers through hospitals, birth centers, and OB/GYN practices. An amendment removed a section that would have required instruction for medical professionals, and the amended bill was reported favorably as a committee substitute. The committee then took up a block of confirmations. Appointees on tabs 2 through 7 were recommended favorably in one vote, and Chavon Harris was separately confirmed as Secretary of the Agency for Health Care Administration after extensive questioning. Senators praised her leadership and experience, while others raised concerns about Medicaid redeterminations, the state’s CORE modernization project, Hope Florida, and a DCF anti-marijuana ad campaign; Harris said she would follow up on some issues and defended the agency’s work on transparency, managed care oversight, and access to care. Her confirmation was recommended favorably, with Sen. Berman noting opposition. Several health-related bills were then heard and advanced. SB 186 by Sen. Garcia expanded epilepsy training requirements for school personnel, including charter school bus drivers, and was reported favorably. SB 902 by Sen. Garcia, after amendments narrowing dental workforce provisions and allowing certain seizure rescue medication delegation to family home health aides, was reported favorably; testimony focused on medical marijuana regulation, practitioner accountability, and concerns about park and child-care proximity restrictions. SB 196 by Sen. Sharif created a uterine fibroid research database with privacy protections and was reported favorably after emotional testimony from a patient and supporters. SB 688 by Sen. Rodriguez would reestablish licensure of naturopathic doctors; it drew both support and skepticism about diagnosis and treatment boundaries, but was reported favorably. SB 1574, Maddie’s Law, would add biliary atresia screening to newborn screening and was strongly supported by parents describing a delayed diagnosis; it was reported favorably. SB 878 on clinical laboratory personnel, SB 1092 on podiatric medicine and certain cellular/tissue-based products, and SB 1032 on medical marijuana registry timelines and veteran fee waivers were also reported favorably, while SB 1032 drew debate over longer renewal/supply periods. The committee then began SB 1760 on Medicaid oversight and program transparency, with the sponsor describing the bill’s creation of a joint legislative oversight committee and a legislative actuary.
ND

North Dakota 2025-2026 Regular Session

House Floor Session Apr 16th, 2025 at 12:30 pm

North Dakota House Floor Meeting

Transcript Highlights:
  • Hospital costs, costs going to doctor, costs of pharmaceuticals are going to change with the market.
  • Hospital cost, costs going to doctor, cost of pharmaceuticals are going to change with the market.
  • But these products are manufactured by pharmaceutical companies, mostly.
  • So pharmaceuticals invent this kind of chemistry, and it's used both in agriculture and for human beings
  • Do any of you have a prescription for a pharmaceutical of some kind? Is it really safe?
Keywords: 908, all
Summary: The House convened with prayer, roll call, and a quorum present, then took up several procedural motions, including suspending House rules for three legislative days and replacing conference committee members on Senate Bill 2282 and SCR 4007. The chamber also recognized visiting student groups from Grafton/Pleasant Valley and Shiloh School. Later, the House agreed to several conference committee reports and moved a number of measures through final passage or final disposition. House Bill 1428, which would have created a sales tax exemption for clothing sold by thrift stores or nonprofit corporations, drew extensive debate over tax policy, revenue loss, and possible conflicts with streamlined sales tax rules. Supporters argued it would help lower-income shoppers and nonprofit thrift stores, while opponents said it created an unfair advantage and could reduce state and local revenue. The conference report was adopted, but the bill ultimately failed on final vote, 37-54. House Bill 1440, relating to cigar lounges, was amended in conference and then passed 75-17. House Bill 1460, concerning adult foster care for private-pay adults, electronic monitoring, and a legislative study, was also adopted and passed overwhelmingly, 91-1. The House then passed Senate Bill 2224, which revises gaming commission structure and gaming stamp requirements, adds Attorney General enforcement provisions, and includes a $25,000 general fund appropriation, by a vote of 88-0. Senate Bill 2327, which expands uses of the agriculture diversification and development fund and appropriates $15 million to it, passed 74-17 after a member was excused from voting due to a personal interest. Senate Bill 2267, creating a regulatory framework for on-site wastewater treatment systems and shifting licensing authority to the Department of Environmental Quality, passed 82-10, and Senate Bill 2276, addressing joint water resource boards for cross-county projects, passed 90-1. The most contentious debate centered on Senate Bill 2160, which would move the state employee health plan from grandfathered status to a non-grandfathered ACA-compliant plan and appropriate about $6.6 million for the transition. Supporters said it would give the PERS board more flexibility, expand preventive and other benefits, and potentially slow premium growth without charging employees premiums. Opponents warned it could raise out-of-pocket costs, add mandated benefits, and shift costs to employees, while also arguing the bill had not been adequately studied. After extended debate, the House passed SB 2160 by a vote of 55-37. The chamber also concurred in Senate amendments to House Bill 1318, a pesticide labeling bill, and placed it on final passage, but the transcript ends before the final vote on that measure.
DE
Transcript Highlights:
  • This straightforward adjustment is essential for controlling escalating pharmaceutical costs and ensuring
  • and the state's health care system will be severely limited, leading to continued skyrocketing pharmaceutical
  • This straightforward adjustment is essential for controlling, escalating pharmaceutical costs and ensuring
  • and the state's health care system will be severely limited, leading to continued skyrocketing pharmaceutical
  • It's important to note that payers across the board typically, pharmaceutical expenditures.
Summary: The committee heard several bills, but much of the meeting focused on House Bill 306, which would require disclosure when a consumer is interacting with a chatbot rather than a human. Sponsor Senator Townsend described it as a consumer protection measure and said the bill is meant to keep pace with rapidly changing AI technology. Committee members and witnesses raised concerns about the bill’s enforcement structure, especially private rights of action and penalties that could apply even without actual consumer harm. The Department of Justice said the bill would apply where the conduct has a Delaware nexus, and that the disclosure requirement is the key consumer protection. Industry witnesses and chambers of commerce opposed the bill as drafted, arguing it would create broad compliance burdens and expose businesses to excessive litigation risk without a harm requirement or clearer safe harbor language. Earlier in the meeting, the committee discussed House Bill 429, which would update Delaware’s step therapy exception process to include biosimilars and interchangeable biologics. Senator Poore and supporters from Highmark and the Department of Insurance said the bill would modernize insurance law, improve access to effective treatments, and reduce costs; they cited national savings from biosimilars and said the bill has agency support. Members asked about Delaware-specific savings, patient switching, and how the process would work, but no vote was taken during the discussion. The committee also heard House Bill 310, which would exclude large data centers from Blue Collar Jobs Act tax credits; the sponsor said the bill is intended to ensure large energy users contribute more to state and local revenues, while supporters and opponents debated competitiveness and community impacts. House Bill 406, on allowing insureds to choose their auto repair shop, and Senate Bill 347, a cleanup bill related to medical debt collection and personal property levies, were also presented without opposition in the hearing. House Bill 253, concerning who may receive letters testamentary or of administration, was described as a cleanup to align statute with existing practice. The committee approved the meeting minutes, but the transcript does not show final votes on the bills discussed.
TX

Texas 89th Regular

Senate Session (Part III) Apr 30th, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • The pharmaceutical industry.
  • There's so much in here other than trying to stop pharmaceutical companies from shipping abortion pharmaceuticals
Bills: HCR35, SJR59, SJR84, SCR30, SB127, SB317, SB324, SB457, SB506, SB511, SB529, SB547, SB584, SB619, SB636, SB646, SB659, SB715, SB732, SB735, SB771, SB784, SB800, SB801, SB904, SB1026, SB1049, SB1065, SB1181, SB1224, SB1250, SB1383, SB1467, SB1524, SB1528, SB1531, SB1568, SB1585, SB1640, SB1681, SB1754, SB1757, SB1777, SB1972, SB1980, SB2007, SB2041, SB2046, SB2050, SB2055, SB2069, SB2080, SB2119, SB2138, SB2139, SB2154, SB2201, SB2225, SB2268, SB2306, SB2308, SB2310, SB2330, SB2366, SB2375, SB2392, SB2401, SB2422, SB2480, SB2514, SB2530, SB2533, SB2543, SB2544, SB2589, SB2610, SB2615, SB2623, SB2660, SB2662, SB2693, SB2695, SB2707, SB2722, SB2742, SB2753, SB2807, SB2843, SB2844, SB2858, SB2880, SB2885, SB2891, SB2925, SB2938, SB2986, SJR3, SJR18, SB5, SB914, SB963, SB1197, SB1415, SB1437, SB1786, SB326, SB767, SB769, SB783, SB1035, SB1271, SB1619, SB1637, SB1806, SB1, SB260, HB135, HB1109, HCR35, HCR64, SJR36, SJR50, SJR63, SJR84, SJR59, SCR12, SCR39, SCR48, SCR19, SCR30, SCR3, SB2023, SB619, SB2742, SB646, SB1026, SB2880, SB62, SB666, SB847, SB284, SB854, SB1073, SB810, SB1505, SB583, SB1502, SB507, SB1434, SB1376, SB1585, SB1772, SB2016, SB1163, SB1122, SB731, SB397, SB508, SB1436, SB287, SB261, SB1882, SB393, SB1791, SB529, SB209, SB2429, SB1999, SB511, SB2309, SB510, SB584, SB1085, SB2046, SB1975, SB2717, SB1262, SB1524, SB636, SB2056, SB884, SB517, SB1200, SB1845, SB1863, SB2681, SB2200, SB2199, SB1757, SB2050, SB2458, SB2201, SB2660, SB2662, SB1065, SB801, SB2533, SB3014, SB3013, SB758, SB1721, SB2366, SB1013, SB2797, SB2383, SB1754, SB2119, SB2448, SB1777, SB1283, SB2392, SB2076, SB2786, SB2876, SB2284, SB2225, SB1540, SB2929, SB1972, SB2540, SB2595, SB2217, SB715, SB2330, SB1383, SB500, SB1640, SB2001, SB2080, SB506, SB2514, SB2753, SB2398, SB1241, SB2927, SB2173, SB2538, SB898, SB1449, SB2529, SB1531, SB2846, SB2476, SB986, SB1181, SB2075, SB2154, SB2864, SB1359, SB2386, SB771, SB2844, SB2550, SB1351, SB1423, SB1931, SB2245, SB2589, SB2707, SB2807, SB410, SB659, SB2776, SB2693, SB2580, SB1980, SB1886, SB1234, SB739, SB456, SB127, SB1666, SB2843, SB2801, SB800, SB2055, SB784, SB2986, SB735, SB1012, SB324, SB2926, SB2938, SB2007, SB2138, SB1242, SB2615, SB1049, SB2310, SB1224, SB2972, SB1568, SB2841, SB2885, SB3016, SB2858, SB2610, SB2139, SB1856, SB2035, SB2308, SB2306, SB2041, SB1528, SB1681, SB1141, SB2401, SB2530, SB2375, SB547, SB1266, SB1373, SB1467, SB2069, SB2269, SB2480, SB2544, SB672, SB904, SB2695, SB2891, SB2422, SB2543, SB1854, SB317, SB2539, SB2532, SB2925, SB1250, SB2082, SB2203, SB457, SB2357, SB2721, SB243, SB1285, SB2568, SB1959, SB1442, SB1454, SB2520, SB2541, SB1708, SB1237, SB1844, SB1586, HB1392, HB22, SB1551, SB3039, SB2819, SB66, SB629, SB1015, SB2342, SB2903, SB2933, SB1965, SB2477, SB3029, SB2605, SB2419, SB1957, SB375, SB250, SB777, SB628, SB2523, SB2367, SB2703, SB2608, SB2778, SB3044, SB2965, SB2521, SB865
ND

North Dakota 2026 1st Special Session

Health Care Committee Feb 12th, 2026 at 09:30 am

Transcript Highlights:
  • Insurance is blaming pharmaceutical and also the hospitals.
  • We're blaming the pharmaceuticals and the insurance industry.
  • Insurance is blaming pharmaceutical and also the hospitals.
  • We're blaming the pharmaceuticals and the insurance industry.
  • Is there any change from the rest of the population in pharmaceuticals?
Keywords: 908, all
Summary: The committee met to review the history and current treatment of North Dakota health insurance mandates, with presentations from Blue Cross Blue Shield of North Dakota, Sanford Health Plan, the Public Employees Retirement System (PERS), and the Insurance Department. The discussion focused on how mandates apply differently to fully insured, self-funded, ACA, Medicaid, and PERS plans; how the state’s benchmark plan and federal essential health benefits affect coverage; and how the existing process requires cost-benefit analysis and, for certain measures, a PERS pilot period before broader application. Presenters also reviewed the long list of existing state mandates, including provider, beneficiary, and coverage requirements, and noted that many were enacted decades ago and have not been revisited despite changes in medical evidence and treatment options. Witnesses from the carriers argued that mandates should be reviewed periodically because some are outdated, can create unintended costs, and may not align with current medical guidance. Examples cited included PSA screening, off-label drug coverage, prior authorization rules, step therapy, and cost-sharing provisions for mental health and substance use treatment. They emphasized that carriers often cover services without a mandate when supported by clinical evidence, and that mandates can shift costs to employers and employees, especially in the fully insured small-group market. They also suggested possible policy improvements such as clearer mandate definitions, better transparency around cost-benefit analyses, a regular 10-year review of mandates, and more timely submission of proposals through the interim process. PERS and the Insurance Department highlighted a recurring tension over what counts as a mandate and when a measure triggers the state’s defrayal obligation under federal law. PERS described its interim committee process, the April 1 deadline for fiscal-impact proposals, and the limited pilot program used for certain measures, noting that only a few bills have gone through the full pilot process. The Insurance Department explained that it views new benefit mandates through the lens of the ACA benchmark plan and essential health benefits, distinguishing true new benefits, such as infertility coverage, from changes to existing benefits, such as telehealth or insulin cost-sharing caps. No votes were taken on policy changes; the meeting was informational, with members asking questions about costs, applicability, transparency, and whether a periodic mandate review should be established.
HI

Hawaii 2025 Regular Session

JHA Public Hearing - Fri Feb 21, 2025 @ 2:00 PM HST

Judiciary & Hawaiian Affairs

Transcript Highlights:
  • History reveals vaccine agendas are often funded by pharmaceutical companies, so we're following the
  • <01:49:06.400> companies<01:49:06.800> so funded by pharmaceutical companies so funded
  • biology anatomy And even Pharmaceuticals biology anatomy And even Pharmaceuticals with<03:42:35.159
  • We the people need you to stand on our side and not on the side of a big pharmaceutical company that
  • <03:43:31.920> company the side of a big pharmaceutical company the side of a big pharmaceutical
Keywords: 910, house, all
Summary: The House Committee on Judiciary and Hawaiian Affairs heard several measures, beginning with HB 194, which would designate May 22 as Maritime Day. Testimony from labor, health, and community groups was in support, and the committee later recommended passage of the bill as is, with several members voting yes and some reserving or being excused. HB 458 would designate April 27 as Brother Joseph Dutton Day; the Department of Accounting and General Services, the Joseph Dutton Guild, and a descendant all supported it, and the committee recommended passage with technical amendments. HB 957 would designate the first Friday in May as Lā‘au Day; support came from the Office of Hawaiian Affairs, the Hawaii Farm Bureau, and many individuals, and the committee recommended passage as is. HB 345 would establish the ʻōpae ula as the state shrimp to promote awareness and protection of anchialine ecosystems; DLNR, Kuaʻāina Ulu ʻAu, and other supporters testified, and the committee recommended passage with technical amendments. The committee also heard HB 901, which would allow public charter schools to appeal directly to the Board of Education on certain operational, governance, or funding matters. The Attorney General and the Public Charter School Commission offered technical comments and suggested amendments, while the commission described its current monitoring and renewal process and said it works closely with schools over the life of a charter contract. Members raised concerns about whether the bill would shift too much work to the Board of Education, and one member voted no when the committee later moved the bill with the Attorney General’s amendments. HB 1066 would add Head Start-related ex officio members to the Early Learning Board; the Early Learning Board and the Executive Office on Early Learning supported it, explaining the changes were needed to align with the federal Head Start Act, and the committee moved it forward without opposition. HB 1069 would add voting members from the Department of Education and Board of Education to the School Facilities Authority Board. DOE and the School Facilities Authority supported the change as a way to strengthen collaboration, though questions from members focused on the current communication process between the agencies. HB 1343 would require the Board of Education to adopt a policy banning student phone and related device use during school hours; the committee noted written testimony in support and then moved to decision-making. At the end of the meeting, the committee adopted recommendations to pass HB 194, HB 458 with technical amendments, HB 957, HB 345 with technical amendments, HB 901 with amendments, HB 1066, HB 1069, and HB 1343.